National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -5 of 5         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


P04467
NCT00539968

Last Modified: 12/27/2004     First Published: 8/24/2003  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Other, Pharmaceutical / Industry


EORTC-16023-10051
SPRI-P01900, NCT00068757

Last Modified: 8/23/2007     First Published: 4/23/2004  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


Over 18


Other, Pharmaceutical / Industry


EORTC-16027
EORTC-26023, SPRI-P03174, NCT00083096


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment


Active


18 and over


Other


174-2004
EU841-03, NCT00288444


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Other


00005027
7009, NCT00612651

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov